Fundraising Fox
Ottimo Pharma
Founded 2020 · 20 employees on LinkedIn · 5 known investors
Find your way into Ottimo Pharma
Sign up to see every warm intro you have to Ottimo Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ottimo Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ottimo is a biotech company developing oncology and immuno-oncology therapeutics, including antibody-based cancer treatments. Its leadership and preclinical work focus on discovery through clinical development of cancer therapies.
Founders & leadership
Ottimo Pharma was founded in 2020 by Jonny Finlay.
Investors · 5
How we know: OrbiMed's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Ottimo Pharma do?
- Ottimo is a biotech company developing oncology and immuno-oncology therapeutics, including antibody-based cancer treatments. Its leadership and preclinical work focus on discovery through clinical development of cancer therapies.
- Who founded Ottimo Pharma?
- Ottimo Pharma was founded by Jonny Finlay in 2020.
- Who are Ottimo Pharma's investors?
- Ottimo Pharma's investors include OrbiMed, Medicxi, Samsara BioCapital, Avoro Capital Advisors, JMI Equity.